A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
ViroMissile, Inc.
Arcus Biosciences, Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Eli Lilly and Company
Baylor College of Medicine
MacroGenics
City of Hope Medical Center
Eli Lilly and Company
OncoNano Medicine, Inc.
NeoTX Therapeutics Ltd.
Rondo Therapeutics
Actym Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Incyte Corporation
Genentech, Inc.
Monopar Therapeutics
Monopar Therapeutics
Seagen Inc.
Sotio Biotech Inc.
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Xencor, Inc.
ADC Therapeutics S.A.
Corvus Pharmaceuticals, Inc.
QuantumLeap Healthcare Collaborative
National Institutes of Health Clinical Center (CC)
Emory University
Canadian Cancer Trials Group
Evelo Biosciences, Inc.
Quadriga Biosciences, Inc.
Imperial College London
MacroGenics
MacroGenics
MacroGenics
Abramson Cancer Center at Penn Medicine
Celgene
Tocagen Inc.
Taizhou EOC Pharma Co., Ltd.
Seagen Inc.
Celldex Therapeutics
Northwestern University
Santa Maria Biotherapeutics
Shenzhen Second People's Hospital
AstraZeneca
Rigshospitalet, Denmark
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)